The Voice of Canadians With Breast Cancer

Education

Our Voices Blog


Tag : drugs

Biosimilars for Cancer: Recent updates to patient treatments

Over the last few years CBCN has been working to educate patients, physicians and the broader cancer advocacy community about biosimilar therapies.  From our curated digital magazine on biosimilars to our recently released white paper Breast Cancer & Biosimilars: Recommendations on Use, Implementation and Patient Communications-CBCN is committed to raising awareness about the use of biosimilar therapies for treating breast cancer.

Why should where you live determine your quality of care? Our new campaign highlights the differences in access to treatments for mBC across Canada

Did you know that accessing treatments for stage IV metastatic breast cancer (mBC) is not universal across Canada? We live in a country that promotes universal health care to all but accessing cancer treatment varies by each province.

A patient’s perspective on MedSearch

Tell us a little bit about yourself, where you’re from, and your experience with breast cancer.

Biosimilars: What are the doctors saying?

Now that you’ve learned more about biosimilars, it may also be of interest to learn what the physician perspective is. We connected with Dr. Sandeep Sehdev, a medical oncologist at the Ottawa Hospital, to get his perspective on biosimilars and what he thinks is important for patients to understand about them.

Learning more about biosimilar treatment options

Biosimilar drugs will soon be entering the breast cancer treatment landscape and are already available for support medications. With these emerging treatment options, it’s important to know more about them so you can make informed decisions about your treatment plan.